Search Results

Ordering information regarding a T4 Total test for Clinical Diagnostic Laboratories. Thyroxine, Total T4 (Total T4) Ordering Recommendation Preferred test for initial screening and monitoring of thyroid function. Methodology Quantitative Electrochemiluminescent Immunoassay (ECLIA) Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube or green (lithium heparin). Also acceptable: lavender Specimen Preparation: Separate serum or plasma from cells ASAP or within 2 hours of collection. Allow serum specimen to clot completely at room temperature. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed specimens. Remarks: Stability: After separation from cells: Ambient: 4 days; Refrigerated: 8 days; Frozen: 1 year Reference Interval Components Available Separately Reference Interval Thyroxine, Total T4 Cord Blood 6.60-17.50 ug/dL 0-3 days 5.37-22.40 ug/dL 4-30 days 5.24-23.20 ug/dL 1-23 months 5.37-16.00 ug/dL 2-6 years 5.26-14.80 ug/dL 7-11 years 5.70-14.10 ug/dL 12-19 years 4.74-14.60 ug/dL 20 years and older 4.50-11.70 ug/dL Interpretive Data Note CPT Code 84436 Components Component Test Code Component Chart Name LOINC 3005980 Thyroxine, Total T4 3026-2 Aliases Syn-Thyroid T4 T4 Serum T4 Total Only Tetraiodothyronine Thyroid Hormone Thyroxine (T4) Total T4

Ordering information regarding a Serine Proteinase 3 (PR3) Antibody for Clinical Diagnostic Laboratories. Serine Proteinase 3 (PR3) Antibody Ordering Recommendation When used in conjunction with other autoantibody tests (ANCA, MPO), may aid in differentiating suspected Wegener granulomatosis (WG) from other vasculitides. May be useful to monitor patients with PR3 antibodies. Panel tests are available. For the workup of suspected vasculitis, refer to ANCA-Associated Vasculitis Profile (ANCA/MPO/PR3) (3003745 ). For patients with a history of vasculitis, refer to Myeloperoxidase (MPO) Antibody and Serine Proteinase 3 (PR3) Antibody with Reflex to Anti-Neutrophil Cytoplasmic Antibody, IgG by IFA (3003746 ). Mnemonic PR3 Performed Mon-Sat Methodology Semi-Quantitative Multiplex Bead Assay Reported 1-2 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.2 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma, urine, or other body fluids. Contaminated, hemolyzed, or severely lipemic specimens., icteric, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 AU/mL or less Negative 20-25 AU/mL 26 AU/mL or greater Equivocal Positive Interpretive Data Approximately 85% of patients with a C-ANCA pattern by IFA have antibodies specific for PR3. Compliance Category: FDA Note CPT Code 83516 Components Component Chart Name Serine Proteinase 3 (PR3) Ab, IgG Component Test Code 0050527 LOINC 6968-2 Aliases PR3 PR3 Ab PR3 IgG Antibodies

The product page for the general Women's Health Panel Clinical Diagnostic Laboratories. Women's Health Panel Feel your best, inside and out. This comprehensive blood panel is designed specifically for women to provide a clear picture of your overall health, hormone balance, and essential nutrients. Whether you’re managing symptoms, staying proactive, or just checking in — this panel helps you take control of your wellness. Here’s what it checks — and why it matters: Complete Blood Count (CBC) – Measures your white and red blood cells to check for signs of fatigue, infection, or anemia. Comprehensive Metabolic Panel (CMP) – Evaluates your liver and kidney function, blood sugar, and electrolyte balance. Lipid Panel – Assesses cholesterol levels, including “good” (HDL) and “bad” (LDL) cholesterol, to help understand your heart health. TSH (Thyroid-Stimulating Hormone) – Screens for thyroid issues that can affect weight, mood, and energy. T4, Total & T3, Free – Additional thyroid hormones that give a fuller view of thyroid function and metabolic health. Estradiol, LH, FSH – These hormones play a major role in reproductive health, menstrual cycles, fertility, and symptoms like hot flashes or irregular periods. Vitamin D – Checks for deficiency in this key vitamin that supports your bones, immune health, and mood. Ferritin – Measures iron storage in the body, which can help explain fatigue, hair thinning, or low energy. One blood draw — no referrals, no insurance required. Just clear answers, fast results, and the confidence to take control of your health. $263.50 Taxes will be calculated at checkout Buy Now

Services for Life Insurance Companies We Care About Your Applicants Clinical Diagnostics Laboratories cares about your applicants and their goal to acquire life insurance. We promise to provide your life insurance applicants with professional laboratory testing to assist in their application process that is done with dignity. We provide laboratory testing using state-of-the-art testing equipment. With the ability to gain results in 24hrs with easy scheduling options . Our highly skilled professionals are on standby to treat your applicants with the highest degree of care and efficiency. Click here today to get started. Contact Us

Ordering information regarding a Glomerular Basement Membrane Antibody test for Clinical Diagnostic Laboratories. Glomerular Basement Membrane Antibody, IgG (IFA) Ordering Recommendation May be useful in detecting glomerular basement membrane (GBM) antibodies. Combined use of IFA Glomerular Basement Membrane Antibody, IgG by Multiplex Bead Assay and IFA (2008403 ) may improve diagnostic sensitivity for disease. If positive, may be useful for monitoring treatment response. Mnemonic GBM-G IFA Performed Mon-Sat Methodology Indirect Fluorescent Antibody Reported 1-3 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transport 1 mL serum. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval Negative Interpretive Data When present, IgG antibody to glomerular basement membrane (GBM) antigen detected by either indirect fluorescent antibody (IFA) or multiplex bead assay helps support a diagnosis of Goodpasture syndrome. However, the combined result of both assays performed during initial evaluation improves the diagnostic sensitivity for disease. A positive result in one or both assays should be confirmed by renal biopsy. This test was developed and its performance characteristics were determined by CDL. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes. Compliance Category: FDA Note CPT Code 86255 Components Component Chart Name GBM Antibody, IgG by IFA Component Test Code 0049191 LOINC 29994-1 Aliases Anti-GBM Antibody Anti-Glomerular Basement Membrane Antibody GBM IgG IFA

Ordering information regarding a Thyroid Stimulating Hormone test for Clinical Diagnostic Laboratories. Thyroid Stimulating Hormone (TSH) Ordering Recommendation Preferred test for initial screening and monitoring of thyroid function. Methodology Quantitative Electrochemiluminescent Immunoassay (ECLIA) Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Plasma separator tube, or serum separator tube SST Specimen Preparation: Separate serum or plasma from cells ASAP or within 2 hours of collection. Allow serum specimen to clot completely at room temperature. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed specimens. Remarks: Stability: After separation from cells: Ambient: Calcium and CO2: 4 hours, All others: 24 hours; Refrigerated: 1 week; Frozen: 2 weeks Reference Interval Components Available Separately Reference Interval Interpretive Data Note CPT Code 84443 Components Component Test Code Component Chart Name LOINC 0070145 Thyroid Stimulating Hormone 3016-3 Aliases Thyrotropin TSH TSH, Pregnancy

Ordering information regarding a Cardiolipin Antibody, IgM test for Clinical Diagnostic Laboratories. Beta-2 Glycoprotein 1 Antibody, IgA Ordering Recommendation Preferred second-line test when seronegative antiphospholipid syndrome (APS) is strongly suspected. Order incrementally or concurrently with other noncriteria antiphospholipid antibody tests. May also be useful in estimating risk of thrombosis and/or pregnancy-related morbidity in patients with SLE. Mnemonic B2GPI A Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, hemolyzed, grossly icteric, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval <=20 SAU Interpretive Data Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86146 Components Component Chart Name B2Glycoprotein 1, IgA Antibody Component Test Code 0050324 LOINC 21108-6 Aliases Anti-B2-Glycoprotein 1 Anti-B2-Glycoprotein I Anti-B2-GP 1 Anti-B2-GP I Anti-B2-GP1 Anti-B2-GPI Anti-Beta-2-Glycoprotein I APOH Apolipoprotein H B2 IgA B2-glycoprotein 1 IgA B2GP1 IgA Beta 2GP1 Ab

View a complete list of participating insurances here at Clinical Diagnostic Laboratories. Contact us for more information. PARTICIPATING INSURANCE COMPANIES Clinical Diagnostics Laboratories will file all claims with the below-listed insurance companies. The list below is not a complete list of Health plans with which CDL participates and is subject to change over time. There may be exceptions in certain areas or for certain members or plans. If you have any questions or do not see your insurance company listed here, please contact us. AARP Adventist HealthCare Aetna (PPO) American Postal Workers Union (APWU) AmeriGroup Health AmeriHealth Anthem Assurant Health Beechstreet Benefit Plan Administrators VA Blue Cross Blue Shield of VA PPO, KeyCare, Cova, Medicare Advantage PPO Anthem Blue Cross (PPO, Medicare PPO)Blue Cross Blue Shield of West VA BRMS Capital Blue Cross (PPO Only) Care Improvement Plus-United Health CareFirst BCBS CareLink CareNet Celtic Insurance ChoiceCare Cigna (Multiplan) Cofinity Compass Rose Conifer Health Solution CoreSource Corvel Coventry National PPO Emblem Health (PPO Only) Empire BCBS (PPO Only) Federal and State Benefit Health Plans FEHBP FedMed Inc First Health National PPO Network Fortis Insurance -Assurant Galaxy Health Network GEHA-(First Health) Geisinger Health Great West HealthAmerica HealthPartners Network HealthScope Services HealthSmart Preferred Networks Highmark BCBS (PPO Only) Horizon BCBS (PPO Only) Humana (All Plans) InterPlan Health Group-HealthSmart John Alden Insurance -Assurant Johns Hopkins Healthcare MagnaCare Mail Handlers Benefit Plan Maryland Physicians Care (MPC) MedCost (NovaNet) Medical Mutual Meritain Health Multiplan National Network NALC- Cigna, Multiplan National Capital PPO, Health Link National Care Network NCN National Claims Administrative Services (NCAS) NovaNet PPO OneNet PPO (United Health Care) Optima Health Network-Valley Health Net Paramount Health Care PayerFusion POMCO Prime Health Services Private Healthcare (PMCS) Pyramid Life Insurance Company Riverside Health(Maryland HealthChoice) Ryan White HIV/Aids Program SAMBA FEP StarMark Insurance Stratrose PPO, NPPN SummaCare PPO (Multiplan, PHCS) SuperMed PPO-1st Medical The Health Plan Three Rivers Provider Network Unicare UnitedHealthcare Virginia Health Network-MedCost Ultra, VHN Plus USA MCO Government Health Plans Medicaid VA, MD, and DC Medicare Advantage PPO Medicare Supplement Railroad Medicare Traditional Medicare Tricare Health Net Federal Services Humana Military TriCare for Life TriWest SCHEDULE AN APPOINTMENT Last Name Email Phone Type your message here... Submit Thanks for submitting! A member of our team will respond to your inquiry as soon as possible.

Ordering information regarding a Cardiolipin Antibody, IgG test for Clinical Diagnostic Laboratories. Cardiolipin Antibody, IgG Ordering Recommendation Acceptable initial test when antiphospholipid syndrome (APS) is strongly suspected. Order with Lupus Anticoagulant Reflexive Panel (0030181 ) and Beta-2 Glycoprotein 1 Antibodies, IgG and IgM (0050321 ). Cardiolipin Antibodies, IgG and IgM (0099344 ) is preferred. Mnemonic AC-IGG Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval <=14 GPL Negative 15-19 GPL Indeterminate 20-80 GPL Low to Moderately Positive 81 GPL or above High Positive Interpretive Data Anti-mitochondrial antibodies (AMA) are thought to be present in 90-95% of patients with primary biliary cholangitis (PBC). However, the frequency of detected antibodies may be cohort or assay dependent, as lower sensitivities have been reported. Not all PBC patients are positive for AMA; some patients may be positive for SP100 and/or GP210 antibodies. A negative result does not rule out PBC. Compliance Category: FDA Note CPT Code 86381 Components Component Chart Name Cardiolipin Antibody IgG Component Test Code 0050901 LOINC 3181-5 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip

Ordering information regarding a Lipid Panel test for Clinical Diagnostic Laboratories. Lipid Panel Ordering Recommendation Use to assess cardiovascular disease risk and guide therapy. Mnemonic Methodology Quantitative Enzymatic Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Refer to individual components. Collect: Plasma separator tube or serum separator tube. Specimen Preparation: Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to a standard transport tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Body fluid (refer to Cholesterol, Fluid; Triglycerides, Fluid; and Chylomicron Screen, Body Fluid). Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 7 days; Frozen: 3 months Reference Interval Interpretive Data An HDL cholesterol less than 40 mg/dL is low and constitutes a coronary heart disease risk factor. An HDL cholesterol greater than 60 mg/dL is a negative risk factor for coronary heart disease. Non-HDL cholesterol is a secondary target of therapy in persons with high serum triglycerides (greater than 199 mg/dL). The goal for non-HDL cholesterol in persons with high triglycerides is 30 mg/dL higher than their LDL cholesterol goal. CHD Risk Factors +1 Men, 45 years and older +1 Women, 55 years and older or premature menopause without estrogen therapy +1 Family history of premature CHD +1 Current smoking +1 Hypertension +1 Diabetes mellitus +1 Low HDL cholesterol: 39 mg/dL or less -1 High HDL cholesterol: 60 mg/dL or greater Desirable Adult Values Higher Risk Borderline Total Cholestorol Triglycerides 199 mg/dL or less 149 mg/dL or less 200-239 mg/dL 150-199 mg/dL 240 mg/dL or greater 200-499 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 129 mg/dL or less (99 mg/dL or less if patient has CHD) 39 mg/dL or less 130-159 mg/dL 160 mg/dL or greater VLDL Cholesterol (calculated) 30 mg/dL or less Desirable Children & Adolescents Higher Risk Borderline Total Cholestorol 169 mg/dL or less 170-199 mg/dL Triglycerides 149 mg/dL or less 150-199 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 109 mg/dL or less 110-129 mg/dL VLDL Cholesterol (calculated) 30 mg/dL or less 200 mg/dL or greater 200-499 mg/dL 39 mg/dL or less 130 mg/dL or greater Note CPT Code 80061 Components Component Test Code 0020031 0020040 0020051 0020053 0020551 0020705 0020008 0020023 0020024 0020025 0020027 0020029 0020030 0020032 0020396 3004293 Component Chart Name Sodium, Serum or Plasma Potassium, Serum or Plasma Chloride, Serum or Plasma Carbon Dioxide, Serum or Plasma Alkaline Phosphatase Aspartate Aminotransferase Alanine Aminotransferase Urea Nitrogen, Serum or Plasma Glucose, Serum or Plasma Creatinine, Serum or Plasma Calcium, Serum or Plasma Protein Total, Serum/Plasma Albumin, Serum or Plasma Bilirubin, Total, Serum or Plasma Anion Gap UH EGFR LOINC 2951-2 2823-3 2075-0 2028-9 6768-6 1920-8 1742-6 3094-0 2345-7 2160-0 17861-6 2885-2 1751-7 1975-2 33037-3 Aliases ACPA Antibody Anti Citrulline Anti-CCP C12 Chem 12 Chemistry Panel Chemistry Screen CMP SMA 12 SMA 20 SMAC